{"id":4074,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2021-10-29","marketCap":459.2664794921875,"name":"Aura Biosciences Inc","phone":"16175008864","outstanding":49.540000915527344,"symbol":"AURA","website":"https://aurabiosciences.com/","industry":"Biotechnology"},"price":9.3125,"year":2024,"month":7,"day":25,"weekday":"Thursday","title":"Historical Stock Price Performance of Aura Biosciences Inc during Significant Market Events","date":"2024-07-25","url":"/posts/2024/07/25/AURA","content":[{"section":"Market Event: Dot-Com Bubble Burst (2000)","text":"During the dot-com bubble burst in 2000, Aura Biosciences Inc was not yet a publicly traded company, and therefore, its stock price was not affected by this market event."},{"section":"Market Event: Global Financial Crisis (2008)","text":"In the midst of the global financial crisis in 2008, Aura Biosciences Inc was still a private company and not publicly traded. Hence, its stock price was not influenced by this market event."},{"section":"Market Event: COVID-19 Pandemic (2020)","text":"The COVID-19 pandemic, which began in early 2020, had a significant impact on global stock markets. As a result, Aura Biosciences Inc's stock price experienced volatility along with the broader market. Initially, there was a sharp decline as uncertainty and fear gripped the markets. However, as the company is engaged in the biotech sector, which was seen as critical during the pandemic, its stock eventually recovered and even outperformed the overall market."},{"section":"Market Event: Vaccine Optimism (Late 2020 and Early 2021)","text":"Towards the end of 2020 and early 2021, as multiple COVID-19 vaccine candidates showed promising results, global stock markets rallied, and Aura Biosciences Inc benefited from this optimism. The company's stock price saw significant gains during this period, driven by the expectation of an eventual return to normalcy and increased demand for biotech products."},{"section":"Market Event: Omicron Variant Concerns (Late 2021)","text":"The emergence of the Omicron variant in late 2021 generated renewed concerns regarding the ongoing COVID-19 pandemic. This led to increased market volatility and a decline in stock prices across various sectors, including biotech. Aura Biosciences Inc's stock price also experienced a temporary setback during this period, reflecting the broader market sentiment."}],"tags":["CrossOver21","Long","Biotechnology"],"news":[{"category":"company","date":1721052660,"headline":"IN BRIEF: Aura Energy receives last permit for Tiris uranium project","id":128713798,"image":"","symbol":"AURA","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=27dofq14md"}]}